Share this article
Share this article
ResearchAndMarkets.com's offering.
The global oncology molecular diagnostics market grew at a CAGR of around 12% during 2014-2019. Looking forward, the global oncology molecular diagnostics market to exhibit strong growth during the next five years.
Oncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell proteins.
Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer. These diagnostics solutions find application in clinical and point-of-care (POC) testing for early detection of cancer. They are also used in blood banks to identify pathogens and infectious diseases present in the donated blood samples.